Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial
L Dogliotti, A Berruti, T Buniva, et al.
International Journal of Oncology
|
July 17, 1998
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients
A Bottini, A Berruti, A Bersiga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Lancet Regional Health. Americas
|
February 13, 2023
Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors
Yunfei Li, Minttu M Rönn, Ashleigh R Tuite, et al.
British Journal of Cancer
|
June 15, 2006
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients
M Tampellini, A Saini, I Alabiso, et al.
Prostate Cancer and Prostatic Diseases
|
March 12, 2008
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease
M Tucci, A Mosca, G Lamanna, et al.
Sexually Transmitted Diseases
|
May 16, 2021
Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States
Rebecca Earnest, Minttu M Rönn, Meghan Bellerose, et al.
Chronobiology International
|
November 6, 2015
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy
M Tampellini, R S Polverari, A Ottone, et al.
Journal of Endocrinological Investigation
|
July 17, 2023
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study
A Dalla Volta, C Palumbo, S Zamboni, et al.
British Journal of Cancer
|
April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G Allevi, C Strina, D Andreis, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial
L Dogliotti, A Berruti, T Buniva, et al.
International Journal of Oncology
|
July 17, 1998
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients
A Bottini, A Berruti, A Bersiga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Lancet Regional Health. Americas
|
February 13, 2023
Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors
Yunfei Li, Minttu M Rönn, Ashleigh R Tuite, et al.
British Journal of Cancer
|
June 15, 2006
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients
M Tampellini, A Saini, I Alabiso, et al.
Prostate Cancer and Prostatic Diseases
|
March 12, 2008
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease
M Tucci, A Mosca, G Lamanna, et al.
Sexually Transmitted Diseases
|
May 16, 2021
Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States
Rebecca Earnest, Minttu M Rönn, Meghan Bellerose, et al.
Chronobiology International
|
November 6, 2015
Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy
M Tampellini, R S Polverari, A Ottone, et al.
Journal of Endocrinological Investigation
|
July 17, 2023
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study
A Dalla Volta, C Palumbo, S Zamboni, et al.
British Journal of Cancer
|
April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G Allevi, C Strina, D Andreis, et al.
Page
of 15